TropNet monitors the use of intravenous artesunate in its member sites and other participating centres in the framework of an observational study. Standardized reports on use of artesunate after completion of treatment are created.

The aim of this study is to obtain better data on efficacy and in particular adverse drug reactions of this drug used to treat a rare disease in Europe.

TropNet member sites but also any other centre in Europe is welcome to contribute to this data.